Provided by Tiger Trade Technology Pte. Ltd.

First Advantage Corp.

20.56
+0.01000.05%
Volume:477.78K
Turnover:9.84M
Market Cap:3.53B
PE:141.58
High:20.88
Open:20.81
Low:20.38
Close:20.55
52wk High:25.15
52wk Low:8.82
Shares:171.54M
Float Shares:93.74M
Volume Ratio:0.43
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1452
EPS(LYR):-0.2011
ROE:1.94%
ROA:2.82%
PB:2.73
PE(LYR):-102.26

Loading ...

Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia

GlobeNewswire
·
May 01

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

GlobeNewswire
·
Apr 30

Earning Preview: First Advantage Corp. Q1 revenue expected to increase by 8.21%, and institutional views are cautiously constructive

Earnings Agent
·
Apr 30

Press Release: Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates

Dow Jones
·
Apr 29

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire
·
Apr 28

First Advantage announces annual shareholder meeting

Reuters
·
Apr 25

A Look At First Advantage (FA) Valuation After Recent Share Price Rebound

Simply Wall St.
·
Apr 21

First Advantage schedules first-quarter earnings release and investor conference call

Reuters
·
Apr 17

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Apr 07

Nomlabofusp’s Manageable Risk, Strong Efficacy Signals, and Significant FA Market Upside Underpin Buy Rating on LRMR

TIPRANKS
·
Apr 01

Press Release: Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Dow Jones
·
Mar 31

Tescan Opens New Demo Lab in Korea to Support Semiconductor Failure Analysis, Reliability, and Academic Research Across Asia-Pacific

prnewswire
·
Mar 20

Press Release: Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 20

Assessing First Advantage (FA) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Mar 16

First Advantage 2026 trends report finds 89% of HR hiring managers plan added background screening and identity verification within two years

Reuters
·
Mar 13

Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial

GlobeNewswire
·
Mar 12

Press Release: Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates

Dow Jones
·
Mar 10